Bioasis Jsc Sofia has applied for the registration of an issue of shares on the Unoffical Market, Segment A, the bourse said.

The issue's value stands at 200,000 leva allocated in as many common shares with a face value of 1 lev and representing te company's capital.

The company's Board of Directors includes Georgios Kisas – executive director and chair, Dimitrios Sotiropoulos – member and Dimitrios Dumbalis – member. Main shareholders are Georgios Kisas (70%) and Dimitrios Sotiropoulos (30%).

Bioasis Jsc's core activity is purchase and resale of goods, commercial representation and intermediation, export and import, wholesale of medical products, disinfectants, hygiene products, cosmetics etc.

The company is a distributor of products in the filed of neurosurgery, invasive cardiology, orthopaedy, rheumatology, intensive care.

Bioiasis Jsc sell its products directly to hospitals, pharmacies and consumers and participates in medical tenders.